COVID-19 Vaccine: PM Narendra Modi interacts with three teams
Centre is working on plans to procure 400-500 million doses of COVID-19 vaccineImage source: Sakal Media Group

COVID-19 Vaccine: PM Narendra Modi interacts with three teams

The teams are from Gennova Biopharmaceuticals Ltd at Pune and Biological E Ltd and Dr Reddy's Laboratories Ltd at Hyderabad

Prime Minister Narendra Modi on Monday held virtual meetings with three teams working on the development and manufacture of vaccines against Covid-19, and discussed the potential of various platforms for vaccine development.

The teams are from Gennova Biopharmaceuticals Ltd at Pune and Biological E Ltd and Dr Reddy's Laboratories Ltd at Hyderabad.

Their potential vaccines are in different stages of trials and detailed data and results are expected from early next year onwards, a Prime Minister's Office (PMO) statement said on Monday.

"The potential of various platforms for vaccine development was also discussed," the statement said. The Prime Minister also asked the companies to come out with their suggestions and ideas regarding the regulatory processes and related matters. He also suggested that they should make extra efforts to inform the general public in simple language about the vaccine and related matters such as its efficacy.

Matters relating to logistics, transport and cold chains in respect of delivery of the vaccines were also discussed. The Prime Minister advised all departments concerned to engage with the manufacturers and seek to resolve matters so that the efforts by these companies bear fruit in order to serve the needs of the country and the entire world.

The Prime Minister praised the efforts made by scientists and researchers in these companies to come out with a vaccine solution to tackle the ongoing coronavirus pandemic, which so far has infected 94,31,692 people across the country, and led to deaths of 1,37,139 patients.

Related Stories

The Bridge Chronicle - Breaking News | Politics, Sports, Business, Lifestyle News from India & World
www.thebridgechronicle.com